Studies of reversible photolysis in oligo-and poly-uridylic acids.

K. Wierzchowski,D. Shugar

Acta Biochimica Polonica

Abstract:

What problem does this paper attempt to address?

The Incidence, Risk Factors, and Patterns of Peripherally Inserted Central Catheter-Related Venous Thrombosis in Cancer Patients Followed Up by Ultrasound

Xiang Li,Guodong Wang,Kun Yan,Shanshan Yin,Hongzhi Wang,Yanjie Wang,Xiumei Bai,Yanfen Shen

DOI: https://doi.org/10.2147/cmar.s301458

2021-01-01

Cancer Management and Research

Abstract:PURPOSE:A peripherally inserted central catheter (PICC) is associated with venous thromboembolism (VTE) especially in patients suffering from cancer. We analyzed the incidence, risk factors, and patterns of PICC-related VTE in cancer patients.PATIENTS AND METHODS:Patients with cancer who underwent PICC placement were evaluated retrospectively. Routine, prospective ultrasound post-PICC placement was used for asymptomatic and symptomatic patients to identify VTE. Multivariable logistic regression models with odds ratios (ORs) were used to examine VTE risk factors.RESULTS:Of 2353 PICCs placed, 165 patients (7.01%) developed PICC-related VTE with a median thrombosis time of 12 days. After adjustment of multivariable analysis, patients with PICC-related VTE were more likely to have a ratio of PICC diameter:vein diameter >0.35 (adjusted OR, 1.689; 95% CI, 1.023-2.789) and high level of triglycerides (1.561; 1.096-2.223). The prevalence of A (adjusted OR, 1.680; 95% CI, 1.009-2.798), B (1.835; 1.137-2.961), and AB (3.275; 1.840-5.829) blood group was significantly higher than that of the O blood group in VTE patients. Venous recanalization was observed in 44.8% (74/165) patients after anticoagulation therapy, and more often in patients with combined deep VTE than in patients with isolated superficial VTE (OR, 17.942; 95% CI, 5.427-59.316). The recanalization time was 20±5 (range, 10-31) days.CONCLUSION:The non-O blood group, larger ratio of PICC diameter:vein diameter, and high level of triglycerides were significantly associated with PICC-related VTE. Almost half of cases of PICC-related deep VTE could be reversed by anticoagulation treatment.
[Clinical Study of Peripherally Inserted Central Catheter-Related Thrombosis and Its Influence on the Blood Flow Status of the Inserted Veins in Cancer Patients]

Hui-Qiong Xu,Xiao-Tian Su,Wen-Li Jing,Hong-Xiu Chen,Jun-Ying Li,Hong-Mei Xie,Xiao-Xia Zhang

DOI: https://doi.org/10.12182/20230560701

Abstract:Objective: To investigate the clinical features of peripherally inserted central catheter (PICC)-related thrombosis (PICCRT) within 2 weeks after PICC placement in cancer patients and its dynamic influence on the blood flow status of veins inserted with catheter, and to provide support for implementing thrombosis prevention and control measures. Methods: Between May 2019 and July 2020, patients who had solid tumors and who had PICC were prospectively enrolled at West China Hospital, Sichuan University. Scheduled color Doppler imaging was performed to examine the status of PICCRT formation at 8 points of time, with the first one conducted one day before the insertion of PICC and the other 7 completed within 2 weeks after the insertion of PICC. Then, based on whether patients had PICCRT, the patients were divided into two groups, a non-PICCRT group and a PICCRT group. The PICCRT group was further divided into two subgroups, an asymptomatic PICCRT group and a symptomatic PICCRT group, according to whether the patients had thrombosis-related symptoms and signs. Comparisons were made to study the incidence of PICCRT and the vascular diameter and the blood flow velocity in the veins inserted with catheters at different points of time in the patients of different groups. Results: Among 173 cancer patients in the cohort, 126 (72.8%) developed PICCRT, all of which occurred within 1 week after PICC insertion. There were 95 cases of asymptomatic PICCRT and 31 cases of symptomatic PICCRT. Before and after PICC insertion, the vascular diameter of both the asymptomatic and symptomatic PICCRT groups was significantly smaller than that of the non-PICCRT group and the blood flow velocity was significantly slower than that of the non-PICCRT group, with the difference continuing to increase with the prolongation of catheter indwelling time. Conclusion: Inserting catheters in veins with bigger vascular diameter and faster blood flow velocity may help reduce the incidence of PICCRT. The first week post catheter insertion is the key intervention period for the prevention of PICCRT.
Management of patients with concurrent primary tumors of bladder and prostate.

C. Selli,W. Hinshaw,J. Wolfe,D. Paulson

DOI: https://doi.org/10.1016/0090-4295(83)90191-7

IF: 2.633

1983-06-01

Urology

Abstract:
ng curve analysis in droplet micro fl uidics for single nucleotide polymorphisms ( SNP ) genotyping

F.-W. Liu,S. Ding,E. Lin,Y.-W. Lu,J. R. Jangc

Abstract:An integrated microchip platform with automated analysis capability for DNA melting curves is developed for Single Nucleotide Polymorphism (SNP) genotyping applications. The microchip contains fluidic channels where genomic DNA samples are encapsulated into a series of droplets and transported through a detection region with a stable temperature gradient. As the temperature is elevated from 60 C to 85 C, the DNA strains denature and the associated fluorescence signals decay with this relationship being acquired as the melting curve. The droplets serve as discrete reactors to conduct DNA melting curve analysis in the liquid phase, eliminating the need for immobilization of reagents. They provide the advantage of signal homogeneity, which reduces the signal fluctuations, and thus the signalto-noise ratio is improved. In addition, a droplet detection and tracking software system which can identify the droplets, records the fluorescence intensities, plots the melting curves, and finds the melting temperatures, is developed making automated SNP genotyping possible. The platform has been verified with genomic DNA from Landrace sows and shown successful SNP discrimination from homozygotes and heterozygotes which demonstrates its potential to conduct on-site SNP genotyping for disease research, medical diagnostics, agriculture, and farm animal reproduction.
Risk factors associated with PICC-related upper extremity venous thrombosis in cancer patients.

Xiao-lei Yi,Jie Chen,Jia Li,Liang Feng,Yan Wang,Jia-An Zhu,E Shen,Bing Hu

DOI: https://doi.org/10.1111/jocn.12227

2013-01-01

Journal of Clinical Nursing

Abstract:AIMS AND OBJECTIVES:To investigate the incidence and risk factors for peripherally inserted central venous catheters-related upper extremity venous thrombosis in patients with cancer. BACKGROUND:With the widespread use of peripherally inserted central venous catheters, peripherally inserted central venous catheters-related upper extremity venous thrombosis in patients with cancer leads to increasing morbidity and mortality. It is very important to further explore the incidence and risk factors for peripherally inserted central venous catheters-related venous thrombosis. DESIGN AND METHODS:Consecutive patients with cancer who were scheduled to receive peripherally inserted central venous catheters, between September 2009 and May 2012, were prospectively studied in our centre. They were investigated for venous thrombosis by Doppler sonography three times a day within 30 days after catheter insertion. Univariable and multivariable logistic regressions' analyses were performed to identify the risk factors for peripherally inserted central venous catheters-related thrombosis. RESULTS:A total of 89 patients with cancer were studied in our research. Of these, 81 patients were followed up within one month. The mean interval between catheter insertion and the onset of thrombosis was 12.45 ± 6.17 days. The multivariable analyses showed that chemotherapy history, less activities and diabetes were the key risk factors for thrombosis. CONCLUSIONS:Peripherally inserted central venous catheters-related upper extremity venous thrombosis had high incidence rate, and most cases had no significant symptoms. The history of chemotherapy, less activities and diabetes were found to be the key risk factors. It should be routinely scanned in high-risk patients every 3-5 days after catheter insertion, which would then find blood clots in time and reduce the incidence of pulmonary embolism. RELEVANCE TO CLINICAL PRACTICE:Risk factors associated with peripherally inserted central venous catheters-related upper extremity venous thrombosis are of critical importance in improving the quality of patients' life. It is very important to grasp the indications to reduce the incidence rate of peripherally inserted central venous catheters-related upper extremity venous thrombosis.
Risk factors of peripherally inserted central catheter-related thrombosis in cancer patients

Li Zhang,Zhenqi Lu,Haiyan Lu,Mei Xue,Xiaoju Zhang

DOI: https://doi.org/10.3870/j.issn.1001-4152.2017.14.051

2017-01-01

Abstract:Objective To explore risk factors of peripherally inserted central catheter (PICC)-related thrombosis in cancer patients.Methods Upper extremities of 1 030 cancer patients who underwent PICC placement were examined by Doppler ultrasound and clinical data of these patients were collected.Results The incidence rate of PICC-related thrombosis in cancer patients was 5.44％,with asymptomatic thrombosis accounting for 76.79％ and symptomatic events accounting for 23.21％.Parenteral nutrition administration,PICC-related complications,hypertension,duration of PICC placement,age greater than 60 years were associated with PICC-related thrombosis (P ＜ 0.05,P ＜ 0.01).Conclusion Asymptomatic PICC-related thrombosis is more common and PICC-related thrombosis is caused by several factors.It is necessary to take targeted measures to reduce the incidence.
A longitudinal observational retrospective study on risk factors and predictive model of PICC associated thrombosis in cancer patients

Xiaomin Song,Hong Lu,Fang Chen,Zuowei Bao,Shanquan Li,Siqin Li,Yinghua Peng,Qiao Liu,Xiaohui Chen,Jingzhen Li,Weimin Zhang

DOI: https://doi.org/10.1038/s41598-020-67038-x

IF: 4.6

2020-06-22

Scientific Reports

Abstract:Abstract To analyze the incidence of PICC associated venous thrombosis. To predict the risk factors of thrombosis. To validate the best predictive model in predicting PICC associated thrombosis. Consecutive oncology cases in 341 who initially naive intended to be inserted central catheter for chemotherapy, were recruited to our dedicated intravenous lab. All patients used the same gauge catheter, Primary endpoint was thrombosis formation, the secondary endpoint was infusion termination without thrombosis. Two patients were excluded. 339 patients were divided into thrombosis group in 59 (17.4%) and non-thrombosis Group in 280 (82.6%), retrospectively. Tumor, Sex, Age, Weight, Height, BMI, BSA, PS, WBC, BPC, PT, D-dimer, APTT, FIB, Smoking history, Location, Catheter length, Ratio and Number as independent variables were analyzed by Fisher’s scoring, then Logistic risk regression, ROC analysis and nomogram was introduced. Total incidence was 17.4%. Venous mural thrombosis in 2 (3.4%), “fibrin sleeves” in 55 (93.2%), mixed thrombus in 2 (3.4%), symptomatic thrombosis in 2 (3.4%), asymptomatic thrombosis in 57 (96.6%), respectively. Height (χ2 = 4.48, P = 0.03), D-dimer (χ2 = 37.81, P < 0.001), Location (χ2 = 7.56, P = 0.006), Number (χ2 = 43.64, P < 0.001), Ratio (χ2 = 4.38, P = 0.04), and PS (χ2 = 58.78, P < 0.001), were statistical differences between the two groups analyzed by Fisher’s scoring. Logistic risk regression revealed that Height (β = −0.05, HR = 0.95, 95%CI: 0.911–0.997, P = 0.038), PS (β = 1.07, HR = 2.91, 95% CI : 1.98–4.27, P < 0.001), D-dimer (β0.11, HR = 1.12, 95% CI : 1.045–1.200, P < 0.001), Number (β = 0.87, HR = 2.38, 95% CI : 1.619–3.512, P < 0.001) was independently associated with PICC associated thrombosis. The best prediction model, D-dimer + Number as a novel co-variable was validated in diagnosing PICC associated thrombosis before PICC. Our research revealed that variables PS, Number, D-dimer and Height were risk factors for PICC associated thrombosis, which were slightly associated with PICC related thrombosis, in which, PS was the relatively strongest independent risk factor of PICC related thrombosis.

multidisciplinary sciences
Clinical Evaluation of the Use of an Intracardiac Electrocardiogram to Guide the Tip Positioning of Peripherally Inserted Central Catheters

Ruiyi Zhao,Chunfang Chen,Jingfen Jin,Komal Sharma,Nan Jiang,Yingqin Shentu,Xingang Wang

DOI: https://doi.org/10.1111/ijn.12409

2015-01-01

International Journal of Nursing Practice

Abstract:The use of peripherally inserted central catheters (PICCs) provides important central venous accesses for clinical treatments, tests and monitoring. Compared with the traditional methods, intracardiac electrocardiogram (ECG)-guided method has the potential to guide more accurate tip positioning of PICCs. This study aimed to clinically evaluate the effectiveness of an intracardiac ECG to guide the tip positioning by monitoring characteristic P-wave changes. In this study, eligible patients enrolled September 2011 to May 2012 according to the inclusion and exclusion criteria received the catheterization monitored by intracardiac ECG. Then chest radiography was performed to check the catheter position. The results revealed that, with 117 eligible patients, all bar one patient who died (n=116) completed the study, including 60 males and 56 females aged 51.2 +/- 15.1 years. Most (n=113, >97%) had characteristic P-wave changes. The intracardiac ECG-guided positioning procedure achieved correct placement for 112 patients (96.56%), demonstrating 99.12% sensitivity and 100% specificity. In conclusion, the intracardiac ECG can be a promising technique to guide tip positioning of PICCs. However, since the sample size in this study is limited, more experience and further study during clinical practice are needed to demonstrate achievement of optimal catheterization outcomes.
Establishment and validation of a predictive model for peripherally inserted central catheter-related thrombosis in patients with liver cancer

Xiao-Fei Chen,Hao-Jun Wu,Tang Li,Jia-Bin Liu,Wen-Jie Zhou,Qiang Guo

DOI: https://doi.org/10.4240/wjgs.v16.i7.2221

2024-07-27

World J Gastrointest Surg

Abstract:Background: Peripherally inserted central catheters (PICCs) are commonly used in hospitalized patients with liver cancer for the administration of chemotherapy, nutrition, and other medications. However, PICC-related thrombosis is a serious complication that can lead to morbidity and mortality in this patient population. Several risk factors have been identified for the development of PICC-related thrombosis, including cancer type, stage, comorbidities, and catheter characteristics. Understanding these risk factors and developing a predictive model can help healthcare providers identify high-risk patients and implement preventive measures to reduce the incidence of thrombosis. Aim: To analyze the influencing factors of PICC-related thrombosis in hospitalized patients with liver cancer, construct a predictive model, and validate it. Methods: Clinical data of hospitalized patients with liver cancer admitted from January 2020 to December 2023 were collected. Thirty-five cases of PICC-related thrombosis in hospitalized patients with liver cancer were collected, and 220 patients who underwent PICC placement during the same period but did not develop PICC-related thrombosis were randomly selected as controls. A total of 255 samples were collected and used as the training set, and 77 cases were collected as the validation set in a 7:3 ratio. General patient information, case data, catheterization data, coagulation indicators, and Autar Thrombosis Risk Assessment Scale scores were analyzed. Univariate and multivariate unconditional logistic regression analyses were performed on relevant factors, and the value of combined indicators in predicting PICC-related thrombosis in hospitalized patients with liver cancer was evaluated using receiver operating characteristic (ROC) curve analysis. Results: Univariate analysis showed statistically significant differences (P < 0.05) in age, sex, Karnofsky performance status score (KPS), bedridden time, activities of daily living impairment, parenteral nutrition, catheter duration, distant metastasis, and bone marrow suppression between the thrombosis group and the non-thrombosis group. Other aspects had no statistically significant differences (P > 0.05). Multivariate regression analysis showed that age ≥ 60 years, KPS score ≤ 50 points, parenteral nutrition, stage III to IV, distant metastasis, bone marrow suppression, and activities of daily living impairment were independent risk factors for PICC-related thrombosis in hospitalized patients with liver cancer (P < 0.05). Catheter duration of 1-6 months and catheter duration > 6 months were protective factors for PICC-related thrombosis (P < 0.05). The predictive model for PICC-related thrombosis was obtained as follows: P predictive probability = [exp (Logit P)]/[1 + exp (Logit P)], where Logit P = age × 1.907 + KPS score × 2.045 + parenteral nutrition × 9.467 + catheter duration × 0.506 + tumor-node-metastasis (TNM) staging × 2.844 + distant metastasis × 2.065 + bone marrow suppression × 2.082 + activities of daily living impairment × 13.926. ROC curve analysis showed an area under the curve (AUC) of 0.827 (95%CI: 0.724-0.929, P < 0.001), with a corresponding optimal cut-off value of 0.612, sensitivity of 0.755, and specificity of 0.857. Calibration curve analysis showed good consistency between the predicted occurrence of PICC-related thrombosis and actual occurrence (P > 0.05). ROC analysis showed AUCs of 0.888 and 0.729 for the training and validation sets, respectively. Conclusion: Age, KPS score, parenteral nutrition, TNM staging, distant metastasis, bone marrow suppression, and activities of daily living impairment are independent risk factors for PICC-related thrombosis in hospitalized patients with liver cancer, while catheter duration is a protective factor for the disease. The predictive model has an AUC of 0.827, indicating high predictive accuracy and clinical value.
Failure of calcium microdomain generation and pathological consequences.

O. Petersen,R. Sutton,D. Criddle

DOI: https://doi.org/10.1016/J.CECA.2006.08.020

IF: 4.69

2006-11-01

Cell Calcium

Abstract:
Thrombotic Risk Factors in Patients Undergoing Chemotherapy Via Peripherally Inserted Central Catheter.

Yulan Shi,Li Wen,Yanyan Zhou,Sifeng Tao

DOI: https://doi.org/10.1177/0300060514527061

2014-01-01

Journal of International Medical Research

Abstract:Objective To evaluate risk factors for venous thrombosis in patients undergoing chemotherapy via peripherally inserted central catheter (PICC). Methods Data regarding age, sex, body mass index (BMI), smoking history, diagnosis, medical history, family history of thrombosis, haemoglobin level, and white blood cell (WBC) and platelet counts were prospectively collected from consecutively recruited patients. Patients were evaluated using six thrombotic risk-assessment scales prior to PICC. Assessments of the general venous system and the catheterized vein and limb were made. Deep vein thrombosis (DVT) was diagnosed by colour Doppler ultrasonography. Thrombosis risk factors were identified by logistic regression analysis. Results Thrombosis occurred in 12/188 patients (6.38%). Age >60 years, BMI >25 kg/m2 and WBC >11.4 × 109/l were identified as independent risk factors for thrombosis. The incidence of thrombosis was 16.6% (12/72) in patients with one or more risk factors, and 55.5% (five of nine) in those with two or more risk factors. Conclusions Age >60 years, BMI >25 kg/m2 and WBC >1.4 × 109/l are major risk factors for thrombosis in Chinese patients undergoing PICC chemotherapy.
Predictive risk factors of venous thromboembolism (VTE) associated with peripherally inserted central catheters (PICC) in ambulant solid cancer patients: retrospective single Centre cohort study

Osamah Al-Asadi,Manar Almusarhed,Hany Eldeeb

DOI: https://doi.org/10.1186/s12959-019-0191-y

2019-01-25

Thrombosis Journal

Abstract:Abstract Aims Peripherally inserted central catheters(PICC) lines are becoming increasingly popular in solid cancer patients for the administration of chemotherapy. This study aims looking at the incidence of PICC line related and distant thromboembolism associated with these catheters and exploring risk factors. Methods Records were reviewed for 158 patients who underwent PICC line insertion over the two years period in the medical oncology unit, Milton Keynes University Hospital. The Incidence PICC line related Deep Venous Thrombosis (DVT) which is defined as upper extremity DVT at the site of PICC line insertion was documented after checking reports of ultrasound Doppler of all symptomatic patients to confirm the presence of thrombo-embolism and Computed Tomography(CT)scan or Computed Tomography Pulmonary Angiography (CTPA) to confirm the presence Pulmonary Embolism(PE). Results 23(13%) symptomatic patients with confirmed diagnosis by ultrasound Doppler were found to have PICC line related DVT and similar number of patients developed distant VTE, namely PE and lower limbs DVT. Average time to thrombo-embolism from the insertion of PICC line was 13 days and 51 days in distant VTE. Statistically significant results have been identified in the term of risk factors leading to VTE events during the period of PICC line insertion. Conclusions VTE is a common complication in medical oncology patients who underwent insertion PICC line insertion for chemotherapy. Risk of distant VTE is high as well as the PICC line related DVT and the risk of the PICC line related DVT is higher in the first two weeks after PICC insertion. We concluded that high BMI,high PLTs count and Fluropyrimidine containing chemotherapy are all significant risk factors for VTE events recorded while smoking and high BMI are significantly contributing to the high rate of the PICC line related DVT.

peripheral vascular disease,hematology
Analysis of factors related to thrombosis in patients with PICC placements

Xiaoli Gao,Xihua Mi,Shiyang Hou,Chunbo Kang

DOI: https://doi.org/10.1097/md.0000000000037168

IF: 1.6

2024-02-03

Medicine

Abstract:Peripherally Inserted Central Catheter (PICC) is a medical device inserted into a patient major blood vessels for the administration of fluids, medications, or blood withdrawal. This catheter is typically inserted into a vein to allow rapid and efficient access to the circulatory system. [ 1 , 2 ] PICC placed through the veins of the human body, can establish a long-term venous route for critically ill patients. Due to its peripheral vein insertion point, broad vascular selectivity, high success rate, minimal trauma, lower infection risk, ease of care, rapid infusion capabilities, and the ability to monitor cardiac function parameters, PICC has become a common intervention for patients requiring long-term intravenous therapy. [ 3 ] The peripherally inserted central catheter (PICC) via peripheral vein puncture is a commonly used intervention for patients requiring long-term intravenous therapy in clinical settings. It effectively reduces puncture frequency, alleviates patient discomfort, and facilitates clinical rescue efforts. [ 4 ] However, the placement of a PICC is a risky process, and long-term PICC use can lead to catheter-related complications, [ 5 ] potentially causing vessel wall damage and thrombus formation. [ 6 ]

medicine, general & internal
Incidence and risk factors of PICC-related thrombosis in breast cancer: a meta-analysis

Fanlun Meng,Shujun Fan,Lingmin Guo,Zhongfeng Jia,Hongjun Chang,Feng Liu

DOI: https://doi.org/10.1093/jjco/hyae055

2024-08-14

Abstract:Background: The incidence and risk factors of peripherally inserted central catheter-related thrombosis in patients with breast cancer have not been fully elucidated. Method: Meta-analysis was performed by searching all studies on the incidence of peripherally inserted central catheter-associated thrombosis and risk factors for its formation in breast cancer patients from the establishment of the database to May 2023, including PubMed, Embase, Web of Science, China Knowledge Network, China Biomedical Literature Service System (SinoMed) and Wanfang databases. Then the incidence of peripherally inserted central catheter-related thrombosis and risk factors for its formation were analyzed in breast cancer patients. Results: A total of 15 articles were included, involving 8635 patients. The total incidence of peripherally inserted central catheter-related thrombosis in breast cancer patients was 7.0% (95% confidence interval: 4.0-13.0%) and 12.9% (95% confidence interval: 7.0-22.5%) after correction. Thirty-two risk factors were included, and eight risk factors could be combined. Among these risk factors, there were statistically significant differences (P < 0.05) in body mass index ≥ 25 (odds ratio = 6.319, 95% confidence interval: 2.733-14.613; P < 0.001), D-dimer >500 ng/ml (odds ratio = 1.436, 95% confidence interval: 1.113-1.854; P = 0.005), increased fibrinogen (odds ratio = 4.733, 95% confidence interval: 1.562-14.346; P = 0.006), elevated platelet count (odds ratio = 4.134, 95% confidence interval: 2.694-6.346; P < 0.001) and catheter malposition (odds ratio = 8.475, 95% confidence interval: 2.761-26.011; P < 0.001). Conclusion: The incidence rate of peripherally inserted central catheter-related thrombosis in breast cancer patients was 7.0% (95% confidence interval: 4.0-13.0%). Body mass index ≥ 25, D-dimer >500 ng/ml, elevated fibrinogen, elevated platelet count and catheter malposition were risk factors for peripherally inserted central catheter-related thrombosis in breast cancer patients.
Comparison on clinical efficacy and adverse reactions between TPICC and ultrasound-guided PICC for advanced tumors: A retrospective study

Yingshan Zheng,Xia Xiang,Lixiang Li,Li Zhang,Shaoli He

DOI: https://doi.org/10.1097/md.0000000000038130

IF: 1.6

2024-10-30

Medicine

Abstract:Peripherally inserted central catheter (PICC), is a peripheral vein puncture, catheter tip enters into central vein. Drugs are directly infused in central vein for avoiding the damage on blood vessels caused by long-term infusion or the infusions from hypertonic and irritating drugs in order to alleviate the pain caused by repeated puncture and improve the quality of life among patients, [ 1 ] which is now widely used in the chemotherapy of tumors or other diseases, [ 2 , 3 ] the parenteral nutritional pathway for adults postoperatively, [ 4 ] and the creation of nutritional pathway for preterm infants, [ 5 ] and so on. Although there are many advantages of PICC, such as avoiding the stimulation of blood vessels caused by drugs for patients who receiving oncology chemotherapy [ 6 ] and reducing the incidence of drug extravasation and the rate of unplanned extubation, etc. [ 7 ] However, some studies have confirmed that the incidence of its related complications is 16.35%. [ 8 ] During PICC intubation, due to improper operation and other reasons, patients may experience catheter separation and secondary dislodgement, resulting in unplanned extubation. The incidence of PICC-related complications not only increases the physical burden of patients, but also increases the cost of treatment. It has been found in studies that the incidence of these problems is related to various factors such as the placement position of catheter, sealing method and catheter material, etc. [ 8–10 ] Therefore, it is extremely important to improve puncture methods for effectively reducing complications and upgrading puncture effects.

medicine, general & internal
Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy

Bing-Xin Lin,Chun-Sen Xu

DOI: https://doi.org/10.2147/IJGM.S296178

IF: 2.145

2021-04-16

International Journal of General Medicine

Abstract:Bing-Xin Lin, Chun-Sen Xu Department of Breast Surgery, Union Hospital of Fujian Medical University, Fuzhou, People's Republic of China Correspondence: Chun-Sen Xu Department of Breast Surgery, Union Hospital of Fujian Medical University, No. 29 of Xinquan Road, Gulou District, Fuzhou, 350001, People's Republic of China Tel/Fax +86 591 83357896 Email Background: To analyze the risk factors of a peripherally inserted central catheter (PICC)-related venous thrombosis in patients with breast cancer undergoing chemotherapy and explore its preventive measures. Methods: Data of 780 patients with breast cancer who underwent PICC chemotherapy in our hospital from January 2014 to June 2015 were retrospectively analyzed. The incidence of catheter-related thrombosis was observed, and related factors of venous thrombosis were analyzed. Results: Among the 780 patients with breast cancer, 36 developed PICC-related venous thrombosis. The incidence of which was 4.62% (36/780). The PICC retention time ranged between 60 and 136 days, and the median time was 92 days. Thrombosis was found to occur within seven days after catheterization in three patients (8.33%), between 7 and 30 days in 18 patients (50%), between 31 and 92 days in 12 patients (33.3%), and ≥ 92 days in three patients (8.33%). Basilic vein puncture-induced thrombosis occurred in 25 patients (3.68%), and median cubital vein and cephalic vein puncture-induced thrombosis occurred in 11 patients (10.78%). The difference was statistically significant (P = 0.001). Thrombosis was not associated with age, punctured limb, platelet count, or chemotherapy drugs (P > 0.05). Conclusion: Blood vessel puncture was the main factor that affected PICC-related thrombosis in breast cancer chemotherapy. The basilic vein should be the primary choice for blood vessel puncture. Prolonged catheter retention does not increase the risk of thrombosis. Keywords: breast cancer, peripherally inserted central catheter, thrombosis

medicine, general & internal
Long Term Studies of Pancreas Transplantation in Experimental Diabetes Mellitus

M. Orloff,S. Lee,A. Charters,D. E. Grambort,L. G. Storck,D. Knox

DOI: https://doi.org/10.1097/00000658-197509000-00003

IF: 13.787

1975-09-01

Annals of Surgery

Abstract:Alloxan diabetes was induced in inbred rats that then were divided into four groups consisting of unoperated diabetic controls, sham-operated diabetic controls, rats given pancreaticoduodenal isografts, and rats given duct-ligated pancreas isografts. The animals were studied for from 18 months (controls) to two years (transplants) and the following important results were obtained: I) In striking contrast to the diabetic controls, pancreas transplants of both types produced immediate and permanent relief of hyperglycemia, immediate and lasting elevation of serum insulin levels, a normal weight and growth curve, and good health for two years. Removal of the graft was followed by recurrence of severe diabetes. 2) Pancreas transplants of both types prevented the widespread and severe renal, ophthalmic and neural lesions of diabetes that were found in the diabetic controls. 3) The ductligated pancreas graft and pancreaticoduodenal transplant were equally effective in controlling diabetes. Ligation of the pancreatic duct was not followed by significant morphologic or clinical evidence of pancreatitis or by loss of endocrine function. 4) Portal venous drainage of the pancreas transplant was unnecessary for good endocrine function.
A prospective sonographic evaluation of peripheral intravenous catheter associated thrombophlebitis

Nicholas Mielke,Steven Johnson,Patrick Karabon,Amit Bahl

DOI: https://doi.org/10.1177/11297298211009019

2021-04-16

The Journal of Vascular Access

Abstract:Objective: Thrombophlebitis associated with peripheral intravenous catheters (PIVCs) is a poorly described complication in the literature. Given limited accuracy of current assessment tools and poor documentation in the medical record, the true incidence and relevance of this complication is misrepresented. We aimed to identify risk factors in the development of thrombophlebitis using an objective methodology coupling serial diagnostic ultrasound and clinical assessment. Methods: We conducted a single-site, prospective observational cohort study. Adult patients presenting to the emergency department that underwent traditionally placed PIVC insertion and were being hospitalized with an anticipated length of stay greater than 2 days were eligible participants. Using serial, daily ultrasound evaluations and clinical assessments via the phlebitis scale, we identified patients with asymptomatic and symptomatic thrombosis. The primary goal was to identify demographic, clinical, and IV related risk factors associated with thrombophlebitis. Univariate and multivariate analyses were employed to identify risk factors for thrombophlebitis. Results: A total of 62 PIVCs were included between July and August 2020. About 54 (87.10%) developed catheter-related thrombosis with 22 (40.74%) of the thrombosed catheters were characterized as symptomatic. Multivariate cox regression demonstrated that catheter diameter relative to vein diameter greater than one-third [AHR = 5.41 (1.91, 15.4) p = 0.0015] and angle of distal tip of catheter against vein wall ⩾5° [AHR = 4.39 (1.39, 13.8) p = 0.0116] were associated with increased likelihood of thrombophlebitis. Conclusions: Our study found that the increased proportion of catheter relative to vein size and steeper catheter tip angle increased the risk of thrombophlebitis. Catheter size relative to vein size is a modifiable factor that should be considered when inserting PIVCs. Additional larger prospective investigations using objective methodologies are needed to further characterize complications in PIVCs.
Effect of feeding precursors on phenylalanine ammonia-lyase activity and coumarin accumulation in leaves of Matricaria chamomilla L.

J. Kováčik,I. Kron,M. Repčák,M. Bačkor

DOI: https://doi.org/10.1007/s10725-007-9172-4

2007-03-17

Abstract:
Exit-Site Care in Austrian Peritoneal Dialysis Centers — a Nationwide Survey

G. Kopriva-Altfahrt,P. König,M. Mündle,F. Prischl,J. Roob,M. Wiesholzer,A. Vychytil

DOI: https://doi.org/10.1177/089686080902900319

2009-05-01

Peritoneal Dialysis International

Abstract:Background Catheter-associated infections markedly contribute to treatment failure in peritoneal dialysis (PD) patients. There is much controversy surrounding prophylactic strategies to prevent these infections. Methods In this nationwide multicenter study we analyzed strategies to prevent catheter-associated infections as performed in Austrian PD centers in 2006. A questionnaire was sent to all 23 PD centers in Austria. Results Ten different catheter models were used in the 332 patients being treated in the 23 Austrian PD centers. Systemic antibiotics prior to catheter placement were given by 17 of the 23 PD centers (glycopeptides, n = 7; cephalosporins, n = 10). Nasal swabs were taken preoperatively by 17 PD centers; nasal Staphylococcus aureus carriers were treated prophylactically with mupirocin cream in 15 of these centers. Dressing change was routinely performed in 318 of 332 chronic PD patients (nonocclusive film dressing, n = 58; gauze dressing, n = 260). Disinfectants for chronic exit-site care included povidone iodine (n = 155), sodium hypochlorite (n = 31), povidone iodine + sodium hypochlorite together (n = 102), and octenidine dihydrochloride/phenoxyethanol (n = 17). Water+non-disinfectant soap or 0.9% sodium chloride was administered as a cleansing agent to the exit site by 27 patients. Routine S. aureus screening (nasal and/or exit-site swabs) in chronic PD patients was performed in 12 PD centers; carriers were treated with mupirocin cream in 11 of these centers. Dialysis staff members were screened for S. aureus in 8 PD centers and spouses were screened for S. aureus in 5 PD centers. The overall exit-site infection rate was 1 episode/43.9 patient-months, tunnel infection rate was 1 episode/88.9 patient-months, and peritonitis rate was 1 episode/51.0 patient-months. Patients of centers that have installed a prophylaxis protocol for treating S. aureus carriers had lower mean infection rates compared with those not using such a protocol. Conclusion Various individual prophylactic strategies are used to prevent catheter-associated infections in Austrian PD centers. Infection rates are within the range reported in the literature. There is still scope for improvement in some centers (e.g., by establishing a prophylaxis protocol).

Studies of reversible photolysis in oligo-and poly-uridylic acids.

The Incidence, Risk Factors, and Patterns of Peripherally Inserted Central Catheter-Related Venous Thrombosis in Cancer Patients Followed Up by Ultrasound

[Clinical Study of Peripherally Inserted Central Catheter-Related Thrombosis and Its Influence on the Blood Flow Status of the Inserted Veins in Cancer Patients]

Management of patients with concurrent primary tumors of bladder and prostate.

ng curve analysis in droplet micro fl uidics for single nucleotide polymorphisms ( SNP ) genotyping

Risk factors associated with PICC-related upper extremity venous thrombosis in cancer patients.

Risk factors of peripherally inserted central catheter-related thrombosis in cancer patients

A longitudinal observational retrospective study on risk factors and predictive model of PICC associated thrombosis in cancer patients

Clinical Evaluation of the Use of an Intracardiac Electrocardiogram to Guide the Tip Positioning of Peripherally Inserted Central Catheters

Establishment and validation of a predictive model for peripherally inserted central catheter-related thrombosis in patients with liver cancer

Failure of calcium microdomain generation and pathological consequences.

Thrombotic Risk Factors in Patients Undergoing Chemotherapy Via Peripherally Inserted Central Catheter.

Predictive risk factors of venous thromboembolism (VTE) associated with peripherally inserted central catheters (PICC) in ambulant solid cancer patients: retrospective single Centre cohort study

Analysis of factors related to thrombosis in patients with PICC placements

Incidence and risk factors of PICC-related thrombosis in breast cancer: a meta-analysis

Comparison on clinical efficacy and adverse reactions between TPICC and ultrasound-guided PICC for advanced tumors: A retrospective study

Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy

Long Term Studies of Pancreas Transplantation in Experimental Diabetes Mellitus

A prospective sonographic evaluation of peripheral intravenous catheter associated thrombophlebitis

Effect of feeding precursors on phenylalanine ammonia-lyase activity and coumarin accumulation in leaves of Matricaria chamomilla L.

Exit-Site Care in Austrian Peritoneal Dialysis Centers — a Nationwide Survey